Improved method for synthesis of low molecular weight protamine-siRNA conjugate
文献类型：期刊论文
| 作者 | Yu, Zhili5; Ye, Junxiao6; Pei, Xing5; Sun, Lu5; Liu, Ergang7; Wang, Jianxin1,2,8; Huang, Yongzhuo3 ; Lee, Seung Jin4; He, Huining5
|
| 刊名 | ACTA PHARMACEUTICA SINICA B
 |
| 出版日期 | 2018-01 |
| 卷号 | 8期号:1页码:116-126 |
| 关键词 | Cell penetrating peptide siRNA Conjugate Conjugation yield Biomimetic delivery Crosslinker |
| ISSN号 | 2211-3835 |
| DOI | 10.1016/j.apsb.2017.11.011 |
| 文献子类 | Article |
| 英文摘要 | RNAi technology has aroused wide public interest due to its high efficiency and specificity to treat multiple types of diseases. However, the effective delivery of siRNA remains a challenge due to its large molecular weight and strong anionic charge. Considering their remarkable functions in vivo and features that are often desired in drug delivery carriers, biomimetic systems for siRNA delivery become an effective and promising strategy. Based on this, covalent attachment of synthetic cell penetrating peptides (CPP) to siRNA has become of great interest. We developed a monomeric covalent conjugate of low molecular weight protamine (LMWP, a well-established CPP) and siRNA via a cytosol-cleavable disulfide linkage using PEG as a crosslinker. Results showed that the conjugates didn't generate coagulation, and exhibited much better RNAi potency and intracellular delivery compared with the conventional charge-complexed CPP/siRNA aggregates. Three different synthetic and purification methods were compared in order to optimize synthesis efficiency and product yield. The methodology using hetero-bifunctional NHS-PEG-OPSS as a crosslinker to synthesize LMWP siRNA simplified the synthesis and purification process and produced the highest yield. These results pave the way towards siRNA biomimetic delivery and future clinical translation. (C) 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. |
| WOS关键词 | CELL-PENETRATING PEPTIDE ; SMALL INTERFERING RNA ; DRUG-DELIVERY ; TARGETED DELIVERY ; THERAPEUTICS ; EFFICIENT ; SYSTEMS ; NANOCOMPLEXES ; NANOPARTICLES ; NANOVECTOR |
| 资助项目 | National Key Research and Development Plan[2016YFE0119200] ; National Natural Science Foundation of China (NSFC)[81402856] ; National Natural Science Foundation of China (NSFC)[81361140344] ; Tianjin Municipal Science and Technology Commission[15JCYBJC28700] ; National Key Basic Research Program of China[2013CB932502] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000426437100013 |
| 出版者 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/272325]  |
| 专题 | 药物制剂研究中心 |
| 通讯作者 | He, Huining |
| 作者单位 | 1.Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201201, Peoples R China; 2.Fudan Univ, Minist Educ, Sch Pharm, Dept Pharmaceut, Shanghai 201201, Peoples R China; 3.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 4.Ewha Womans Univ, Dept Pharm, Seoul 120750, South Korea 5.Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China; 6.Tsinghua Univ, Coll Pharm, Beijing 100084, Peoples R China; 7.Tianjin Univ, Collaborat Innovat Ctr Chem Sci & Chem Engn & Tec, Tianjin 300072, Peoples R China; 8.PLA, Shanghai 201201, Peoples R China; |
| 推荐引用方式 GB/T 7714 | Yu, Zhili,Ye, Junxiao,Pei, Xing,et al. Improved method for synthesis of low molecular weight protamine-siRNA conjugate[J]. ACTA PHARMACEUTICA SINICA B,2018,8(1):116-126. |
| APA | Yu, Zhili.,Ye, Junxiao.,Pei, Xing.,Sun, Lu.,Liu, Ergang.,...&He, Huining.(2018).Improved method for synthesis of low molecular weight protamine-siRNA conjugate.ACTA PHARMACEUTICA SINICA B,8(1),116-126. |
| MLA | Yu, Zhili,et al."Improved method for synthesis of low molecular weight protamine-siRNA conjugate".ACTA PHARMACEUTICA SINICA B 8.1(2018):116-126. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。